Interestingly, in clinical trials for 2.4 mg semaglutide, only 0.2% of 407 participants reported a burning sensation, which highlights the importance of proper injection technique
Graphics by Brian Olson
Clinical Disclaimer This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment
The first case involves a 54-year-old man who, about one month after starting semaglutide, experienced a marked decline in energy, motivation, fatigue, difficulty concentrating, and mood disturbances
The SURMOUNT trials demonstrated up to 22.5% mean weight loss at the highest dose
Two well-rotated sites are better than three sites where one consistently delivers medication into muscle